Other Clinical Trial - MonaLisa Touch Randomized Double-Blind Placebo

Status Completed

Clinical Trial Summary

Aim of the study: To assess the efficacy of MonaLisa Touch procedure for the management of genitourinary syndrome of menopause (GSM) in a randomized double-blind placebo controlled study.

Clinical Trial Description

Study design: Randomly assigning the intervention can eliminate the influence of unknown or immeasurable confounding variables that may otherwise lead to biased and incorrect estimate of treatment effect. Also, randomization eliminates confounding by baseline variables and blinding eliminates confounding by co-interventions, thus eliminating the possibility that the observed effects of intervention are due to differential use of other treatments. The best comparison is placebo control that allows participants, investigators and study staff to be blinded. The advantage of trial over an observational study is the ability to demonstrate causality.

Background: Genitourinary syndrome of Menopause is a condition of postmenopausal women due to estrogen deprivation which results in progressive worsening of the vaginal and vulvar anatomy with symptoms of vulvar itching or pain during intercourse, vaginal dryness, urinary urgency and frequency and frequent bladder infections. It could ultimately lead to vaginal bleeding, petechial hemorrhages, vaginal narrowing or stenosis and hypertonicity of the pelvic muscles due to anticipation of coital pain. The hypertonicity by itself can cause pelvic pressure or pain.

Thus, GSM is a chronic progressive disease state that if left untreated could have dire vaginal and urogynecological consequences.

MonaLisa Touch is a fractional CO2 laser that has been specially designed with the DEKA pulse to stimulate vaginal tissue. It is delivered in a very precise manner and results in the synthesis of collagen and stratification of the vaginal epithelium with improvement of the vaginal pH and moisturization of the vaginal tissue due to increased blood flow and turgidity of the ground substance from the synthesis of the proteoglycans, hyaluronic acid and collagen.

Initial trials on MonaLisa Touch have shown promising results with significant improvement in vaginal exams and patient satisfaction scores. ;

Study Design

Related Conditions & MeSH terms

Genitourinary Syndrome of Menopause

Clinical Trial Details

NCT number	NCT03331328
Study type	Interventional
Source	Michigan Institution of Women's Health PC
Contact
Status	Completed
Phase	N/A
Start date	September 13, 2017
Completion date	July 10, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05812924` - A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause	Phase 2
Completed	`NCT04535323` - Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer	Phase 1
Recruiting	`NCT04746456` - Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROM
Withdrawn	`NCT04606550` - MonaLisa Laser Intervention for Post-Menopausal Breast Cancer Patients: A SHE CAN Study	N/A
Completed	`NCT04705883` - Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors	Phase 4
Recruiting	`NCT05953090` - VALOR: Vaginal Atrophy & Long-term Observation of Recovery	N/A
Active, not recruiting	`NCT04619485` - Sexual and Vaginal Health in Breast Cancer Women Receiving Aromatase Inhibitors Before and After CO2 Laser Therapy	N/A
Completed	`NCT04607798` - Multi-polar RF and PEMF for Treatment of Vulvovaginal Atrophy	N/A
Recruiting	`NCT06124820` - RCT Comparing Intravaginal Laser Therapy to Sham in Post-menopausal Women With Recurrent Urinary Tract Infections	N/A
Completed	`NCT05561972` - The Ultrasonographic Assessment of Efficacy of Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause	N/A
Recruiting	`NCT05571527` - Comparison of Vaginal Hyaluronic Acid Treatment Over Autologous Platelet Rich Plasma Treatment for Genitourinary Syndrome of Menopause	N/A
Recruiting	`NCT04677491` - Effects of Ospemifene on Brain Activation Patterns in Women With Sexual Interest-arousal Disorders	Phase 4
Not yet recruiting	`NCT06425978` - Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit	Phase 4
Recruiting	`NCT05672901` - Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause	N/A
Recruiting	`NCT03782480` - Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy	Phase 3
Recruiting	`NCT06028009` - PRP Injections for Genitourinary Syndrome of Menopause	N/A
Not yet recruiting	`NCT06007027` - Vaginal CO2 Laser Therapy for Genitourinary Syndrome in Breast Cancer Survivors	N/A
Terminated	`NCT03857893` - New Non-Hormonal Treatment by Radiofrequency for Vulvo-Vaginal Atrophy	N/A
Completed	`NCT05782920` - Management of Cancer Therapy Related Vulvovaginal Atrophy	N/A
Completed	`NCT05464654` - Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

MonaLisa Touch Randomized Double-Blind Placebo Controlled Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms